Stepwise deep neural network (stepwise-net) for head and neck auto-segmentation on CT images.

CNN Deep learning Segmentation

Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 27 11 2021
revised: 08 01 2022
accepted: 02 02 2022
pubmed: 16 2 2022
medline: 16 2 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

The current study aims to propose the auto-segmentation model on CT images of head and neck cancer using a stepwise deep neural network (stepwise-net). Six normal tissue structures in the head and neck region of 3D CT images: Brainstem, optic nerve, parotid glands (left and right), and submandibular glands (left and right) were segmented with deep learning. In addition to a conventional convolutional neural network (CNN) on U-net, a stepwise neural network (stepwise-network) was developed. The stepwise-network was based on 3D FCN. We designed two networks in the stepwise-network. One is identifying the target region for the segmentation with the low-resolution images. Then, the target region is cropped, which used for the input image for the prediction of the segmentation. These were compared with a clinical used atlas-based segmentation. The DSCs of the stepwise-net was significantly higher than the atlas-based method for all organ at risk structures. Similarly, the JSCs of the stepwise-net was significantly higher than the atlas-based methods for all organ at risk structures. The Hausdorff distance (HD) was significantly smaller than the atlas-based method for all organ at-risk structures. For the comparison of the stepwise-net and U-net, the stepwise-net had a higher DSC and JSC and a smaller HD than the conventional U-net. We found that the stepwise-network plays a role is superior to conventional U-net-based and atlas-based segmentation. Our proposed model that is a potentially valuable method for improving the efficiency of head and neck radiotherapy treatment planning.

Identifiants

pubmed: 35168082
pii: S0010-4825(22)00087-7
doi: 10.1016/j.compbiomed.2022.105295
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105295

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Daisuke Kawahara (D)

Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan. Electronic address: daika99@hiroshima-u.ac.jp.

Masato Tsuneda (M)

Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.

Shuichi Ozawa (S)

Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, 732-0057, Japan.

Hiroyuki Okamoto (H)

Department of Medical Physics, National Cancer Center Hospital, Tokyo, 104-0045, Japan.

Mitsuhiro Nakamura (M)

Division of Medical Physics, Department of Information Technology and Medical Engineering, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.

Teiji Nishio (T)

Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.

Akito Saito (A)

Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.

Yasushi Nagata (Y)

Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan; Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, 732-0057, Japan.

Classifications MeSH